ANSAL IPS at CPHI Milan 2026: Strengthening Partnerships and Exploring New Opportunities

October 2026 | Company News & Events

Representatives of ANSAL Integrated Pharma Solutions attended CPHI Milan 2026 as visitors, meeting with international pharmaceutical manufacturers, technology providers and industry partners to strengthen existing relationships and explore new opportunities for cooperation.

The exhibition brought together a diverse range of pharmaceutical companies, including established European manufacturers, Chinese technology providers and businesses from emerging markets.

For ANSAL IPS, visiting CPHI Milan provided a valuable opportunity to exchange perspectives, reconnect with business partners and gain further insights into the evolving needs of pharmaceutical companies across different regions.

Strengthening Established International Partnerships

During our visit, we were pleased to reconnect with valued business partners, including EDA Trading and HPM.

These meetings provided opportunities to discuss ongoing cooperation, exchange perspectives and explore potential areas for future collaboration.

At ANSAL IPS, we believe that successful international pharmaceutical partnerships are built on trust, continuity and a shared understanding of long-term objectives.

Maintaining close relationships with our partners is therefore an essential part of our approach to international business development.

Expanding Our International Technology Network

CPHI Milan also provided opportunities to establish new contacts with pharmaceutical manufacturers and technology providers from China and Europe.

Among these new connections was Canaan, a Chinese provider of pharmaceutical manufacturing equipment and integrated solutions.

Our discussions offered insights into Canaan’s approach to pharmaceutical manufacturing technologies and integrated technical solutions.

Establishing connections with technology providers such as Canaan helps ANSAL IPS broaden its international network and identify potential solutions for future pharmaceutical manufacturing and localization opportunities.

Connecting with the MENA Pharmaceutical Industry

Another important aspect of our visit was meeting pharmaceutical companies from the Middle East and North Africa.

These discussions helped us better understand their priorities and ambitions, particularly in relation to innovative pharmaceutical products, manufacturing capabilities, technology transfer and localization.

As pharmaceutical industries across the region continue to develop, connecting local companies with suitable international technologies and partners remains an important opportunity.

ANSAL IPS seeks to contribute by facilitating strategic partnerships, supporting technology transfer and helping pharmaceutical companies evaluate and develop potential cooperation opportunities.

Bridging Innovation with Accessibility

Our discussions at CPHI Milan reinforced a central principle of ANSAL IPS:

Pharmaceutical innovation creates its greatest value when it can be translated into practical solutions that reach patients.

Achieving this requires more than access to innovative products or advanced technologies. It depends on sustainable partnerships, technical capabilities, regulatory readiness and a clear understanding of regional market needs.

By connecting international pharmaceutical expertise with local industry ambitions, ANSAL IPS continues working toward its mission:

Bridging Innovation with Accessibility.

We thank our existing partners and the industry colleagues we met in Milan for the constructive discussions and look forward to continuing these exchanges and exploring opportunities for future cooperation.